Dr. Marcella Anne Calfon Press, MD, PhD

Dr. Press practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Press' NPI, 1053427823, was assigned on August 22, 2006. Dr. Press graduated from New York University School of Medicine in 2004. Dr. Press' California license number on file is A120911.

Dr. Press' primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Press' primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Press is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Press to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Press practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Press' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Press is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Press' licenses on file in 3 states: California, Tennessee and Massachusetts.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Press treats.

CMS data shows 1,617 Medicare services from Dr. Press across 17 procedure codes in 2024, for 635 Medicare patients. Medicare paid $130,103 for them.

CMS counts 635 Medicare patients who saw Dr. Press in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Press' median patient age at 66, with 53% women.

In 2024, Dr. Press wrote 3,897 Medicare Part D claims for 603 patients. 87% of them were for generic drugs. CMS names the drug for 3,647 of them, across 41 drugs with 11 or more claims each, at $523,361 in total drug cost. In 2023, CMS named 3,728 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Press for performance year 2024, reported as part of a group. Dr. Press accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Press as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Press, published from 2016 to 2023. 2020 was the busiest year, with 3. Dr. Press' most frequent co-authors are Asim Rafique, MD, Olcay Aksoy, MD and Rushi V. Parikh.

CMS Open Payments shows 220 general payments to Dr. Press from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 40% of the total. Abbott Laboratories paid the most, $27,345.

Dr. Press graduated from New York University School of Medicine in 2004.

Dr. Press is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.